Peptide directoryGut, pancreas & liver

IGF-2

The fetal growth factor, switched on from the father’s copy of the gene.

Where it comes from

Made in
Liver and most tissues before birth; the liver mainly after
Sent out by
Steady; not under growth hormone in adults
Acts on
  • Fetal tissues
  • Muscle
  • Tumours that make it

What it does

  • Drives fetal and placental growth 1
  • Supports muscle repair and regeneration
  • Circulates in adults at three times the level of IGF-1, with no settled job

In medicine

  • Too much IGF2 expression causes the overgrowth of Beckwith-Wiedemann syndrome; too little, Silver-Russell syndrome 1
  • Tumours that secrete an incompletely processed “big IGF-2” cause hypoglycaemia, because it escapes the binding proteins and acts on the insulin receptor 2

Beyond the body’s own use

  • Not used as a medicine: there is no IGF-2 product, and the clinical problem it causes is too much of it rather than too little
  • Blocking it is the direction of interest, in the cancers that make it, and that work is at the stage of antibodies and receptor inhibitors rather than trials 2
  • In rodents, injected IGF-2 strengthened recall and the effect lasted weeks, which made it a memory candidate 3. It has not been tested in people, and the imprinting that controls the gene makes any attempt to raise it in a person a long way off

Sources

  1. Brioude et al., Diagnosis and management of Beckwith-Wiedemann syndrome: international consensus statement, Nature Reviews Endocrinology 2018
  2. Crowley et al., IGF-2 mediated hypoglycaemia: a case report and review of the literature, BMC Endocrine Disorders 2022
  3. Chen et al., A critical role for IGF-II in memory consolidation and enhancement, Nature 2011

This card describes what a medicine is for and what the evidence says; it recommends nothing. Talk to your clinician about anything you read here.